Novartis Investidative Site

Nuremberg

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Renal Cell Cancer

Studies at this site

• Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy — NO_LONGER_AVAILABLE